Sale of Interest in China Cord Blood Corporation

Represented China Cord Blood Corporation (CCBC) in connection with the sale by Golden Meditech Holdings Ltd. of CCBC’s 7 percent senior convertible note, due 2017 in aggregate principal amount of US$50 million, to Magnum Opus International Holdings Ltd. and Cordlife Group Ltd. for approximately US$88 million.